These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Endocannabinoid and Prostanoid Crosstalk in Pain. Buisseret B; Alhouayek M; Guillemot-Legris O; Muccioli GG Trends Mol Med; 2019 Oct; 25(10):882-896. PubMed ID: 31160168 [TBL] [Abstract][Full Text] [Related]
46. Orofacial pain education in dentistry: A path to improving patient care and reducing the population burden of chronic pain. Costa YM; De Koninck BP; Elsaraj SM; Exposto FG; Herrero Babiloni A; Kapos FP; Sharma S; Shimada A J Dent Educ; 2021 Mar; 85(3):349-358. PubMed ID: 33098113 [TBL] [Abstract][Full Text] [Related]
48. Orofacial pain management: current perspectives. Romero-Reyes M; Uyanik JM J Pain Res; 2014; 7():99-115. PubMed ID: 24591846 [TBL] [Abstract][Full Text] [Related]
49. UHPLC-ESI-MS/MS assay for quantification of endocannabinoids in cerebrospinal fluid using surrogate calibrant and surrogate matrix approaches. Aydin E; Cebo M; Mielnik J; Richter H; Schüle R; Sievers-Engler A; Młynarz P; Lämmerhofer M J Pharm Biomed Anal; 2023 Jan; 222():115090. PubMed ID: 36252552 [TBL] [Abstract][Full Text] [Related]
50. Application of ICHD-II criteria for headaches in a TMJ and orofacial pain clinic. Kang JK; Ryu JW; Choi JH; Merrill RL; Kim ST Cephalalgia; 2010 Jan; 30(1):37-41. PubMed ID: 19438924 [TBL] [Abstract][Full Text] [Related]
51. Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa. Collu R; Scherma M; Piscitelli F; Giunti E; Satta V; Castelli MP; Verde R; Fratta W; Bisogno T; Fadda P Int J Eat Disord; 2019 Nov; 52(11):1251-1262. PubMed ID: 31456239 [TBL] [Abstract][Full Text] [Related]
52. Possible Anandamide and Palmitoylethanolamide involvement in human stroke. Naccarato M; Pizzuti D; Petrosino S; Simonetto M; Ferigo L; Grandi FC; Pizzolato G; Di Marzo V Lipids Health Dis; 2010 May; 9():47. PubMed ID: 20470384 [TBL] [Abstract][Full Text] [Related]
53. The differential impact of neuropathic, musculoskeletal and neurovascular orofacial pain on psychosocial function. Smith JG; Karamat A; Melek LN; Jayakumar S; Renton T J Oral Pathol Med; 2020 Jul; 49(6):538-546. PubMed ID: 32531812 [TBL] [Abstract][Full Text] [Related]
54. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism. Starowicz K; Makuch W; Korostynski M; Malek N; Slezak M; Zychowska M; Petrosino S; De Petrocellis L; Cristino L; Przewlocka B; Di Marzo V PLoS One; 2013; 8(4):e60040. PubMed ID: 23573230 [TBL] [Abstract][Full Text] [Related]
55. Migraine is the most prevalent primary headache in individuals with temporomandibular disorders. Franco AL; Gonçalves DA; Castanharo SM; Speciali JG; Bigal ME; Camparis CM J Orofac Pain; 2010; 24(3):287-92. PubMed ID: 20664830 [TBL] [Abstract][Full Text] [Related]
56. Endocannabinoids as potential biomarkers: It's all about pre-analytics. Kratz D; Thomas D; Gurke R J Mass Spectrom Adv Clin Lab; 2021 Nov; 22():56-63. PubMed ID: 34939056 [TBL] [Abstract][Full Text] [Related]
57. Endocannabinoid Levels in Ulcerative Colitis Patients Correlate With Clinical Parameters and Are Affected by Cannabis Consumption. Tartakover Matalon S; Azar S; Meiri D; Hadar R; Nemirovski A; Abu Jabal N; Konikoff FM; Drucker L; Tam J; Naftali T Front Endocrinol (Lausanne); 2021; 12():685289. PubMed ID: 34531823 [TBL] [Abstract][Full Text] [Related]
58. Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain. Leishman E; Cornett B; Spork K; Straiker A; Mackie K; Bradshaw HB Pharmacol Res; 2016 Aug; 110():159-172. PubMed ID: 27109320 [TBL] [Abstract][Full Text] [Related]
59. Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine. Greco R; Demartini C; Francavilla M; Zanaboni AM; Tassorelli C Cells; 2021 Sep; 10(10):. PubMed ID: 34685523 [TBL] [Abstract][Full Text] [Related]
60. Biochemical changes in endocannabinoid system are expressed in platelets of female but not male migraineurs. Cupini LM; Bari M; Battista N; Argirò G; Finazzi-Agrò A; Calabresi P; Maccarrone M Cephalalgia; 2006 Mar; 26(3):277-81. PubMed ID: 16472333 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]